PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Sinonasal renal cell-like adenocarcinoma, a unique variant of primary clear cell carcinoma of the head and neck: The first reported case in Korea.

Abstract Primary sinonasal renal cell-like adenocarcinoma (SNRCLA) is a rare and unique neoplasm.
PMID
Related Publications

Adenoid cystic carcinomas invading the skull base. Apropos of 4 cases and review of the literature.

Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results.

Sinonasal intestinal-type adenocarcinoma involvement of the paranasal sinuses.

Sinonasal renal cell-like adenocarcinoma: a report on four patients.

Primary clear cell carcinoma of the skull base and paranasal cavity: a case report.

Authors

Mayor MeshTerms

Ethmoid Sinus

Keywords
Journal Title medicine
Publication Year Start




PMID- 28767609
OWN - NLM
STAT- MEDLINE
DA  - 20170802
DCOM- 20170822
LR  - 20170822
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 31
DP  - 2017 Aug
TI  - Sinonasal renal cell-like adenocarcinoma, a unique variant of primary clear cell 
      carcinoma of the head and neck: The first reported case in Korea.
PG  - e7711
LID - 10.1097/MD.0000000000007711 [doi]
AB  - RATIONALE: Primary sinonasal renal cell-like adenocarcinoma (SNRCLA) is a rare
      and unique neoplasm. PATIENT CONCERNS: A 63-year-old man presented with repeated 
      epistaxis, nasal obstruction and hyposmia of 2-month duration. Radiological
      studies revealed a mass of the left ethmoid sinus involving anterior skull base. 
      DIAGNOSIS: The patient was treated with craniofacial resection, bifrontal
      craniotomy combined with an endonasal endoscopic approach. Intraoperatively, a
      hypervascular paranasal mass invading the dura mater was removed en block.
      Histologically, the tumor resembled a clear cell renal cell carcinoma, with
      cuboidal shaped cells having clear cytoplasm. The tumor cells were positive for
      CK7, S100, vimentin and PAX-8 and negative for CD10 and PAX-2 by
      immunohistochemistry. No evidence of renal malignancy was found by radiological
      and clinical examinations. INTERVENTIONS AND OUTCOMES: Following local radiation 
      therapy, the patient was in good health without recurrence for 15 months after
      the operation. LESSONS: To the best of the authors' knowledge, this is the first 
      reported case of SNRCLA in Korea. Because of its histological feature of clear
      cytoplasm, SNRCLA needs to be differentiated from clear cell renal cell carcinoma
      and other salivary clear cell carcinomas. The prognosis of SNRCLA is generally
      favorable as shown in the previously reported cases. Considering the limited
      number and follow-up periods of the cases, however, delayed recurrence should be 
      kept in mind for clinicians.
FAU - Kim, Nah-Ihm
AU  - Kim NI
AD  - aDepartment of Pathology bDepartment of Otolaryngology-Head and Neck Surgery
      cDepartment of Neurosurgery, Chonnam National University Hwasun Hospital and
      Medical School, Hwasun, Jeollanamdo, South Korea.
FAU - Yang, Jung-In
AU  - Yang JI
FAU - Kim, Sung-Sun
AU  - Kim SS
FAU - Lee, Ji-Shin
AU  - Lee JS
FAU - Lim, Sang-Chul
AU  - Lim SC
FAU - Jung, Shin
AU  - Jung S
FAU - Lee, Jae-Hyuk
AU  - Lee JH
FAU - Moon, Kyung-Sub
AU  - Moon KS
FAU - Lee, Kyung-Hwa
AU  - Lee KH
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - AIM
SB  - IM
MH  - Adenocarcinoma, Clear Cell/*diagnosis/pathology/surgery/therapy
MH  - Carcinoma, Renal Cell/*diagnosis
MH  - Diagnosis, Differential
MH  - *Ethmoid Sinus
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Paranasal Sinus Neoplasms/*diagnosis/pathology/therapy
MH  - Skull Base Neoplasms/diagnosis/*pathology/surgery
EDAT- 2017/08/03 06:00
MHDA- 2017/08/23 06:00
CRDT- 2017/08/03 06:00
AID - 10.1097/MD.0000000000007711 [doi]
AID - 00005792-201708040-00045 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Aug;96(31):e7711. doi: 10.1097/MD.0000000000007711.